“Whoa! It's like Spotify but for academic articles.”

Instant Access to Thousands of Journals for just $40/month

Get 2 Weeks Free

Purification of carboxypeptidase G‐1 by immunoadsorption

INTRODUCTION Carboxypeptidase G-1 (CPG-l), an enzyme under study as a possible chemotherapy agent, is produced on pilot plant scale at the New England Enzyme Center. This enzyme cleaves glutamic acid carboxyl from folates and methotrexate. It is a constitutive enzyme from a microorganism isolated a t the Enzyme Center but not yet classified and is identical to the enzyme reported by McCullough e t al.1 Purification by immunosorption was studied as a possible large scale isolation method. PROCEDURE Prepardlion of Immunosorbent Antiserum to carboxypeptidase G-1 was produced by inoculating New Zealand rabbits with 0.5 ml of enzyme with a specific activity of between 375 to 520 units/mg protein in complete Freund's adjuvant. Antiserum to enzyme contaminants was also produced by inoculating 0.7 mg of contaminant protein into a rabbit. The rabbit serum was drawn weekly and fractionated to immunoglobulin. The various antisera were attached to newly activated Sepharose 2B, e.g., see ref. 2. The immunosorbent contained about 20 mg protein/g of filtered dry Sepharose. Immunosorption purification of CPG-1 About three parts of crude enzyme solution and one part of immunosorbent were mixed gently for 2 hr to permit the enzyme to complex with the immunosorbent. The suspension was http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Biotechnology and Bioengineering Wiley

Loading next page...

You're reading a free preview. Subscribe to read the entire article.

And millions more from thousands of peer-reviewed journals, for just $40/month

Get 2 Weeks Free

To be the best researcher, you need access to the best research

  • With DeepDyve, you can stop worrying about how much articles cost, or if it's too much hassle to order — it's all at your fingertips. Your research is important and deserves the top content.
  • Read from thousands of the leading scholarly journals from Springer, Elsevier, Nature, IEEE, Wiley-Blackwell and more.
  • All the latest content is available, no embargo periods.